Pharmaceutical products; requiring publishing of certain information by manufacturers. Effective date.

Summary

The bill forces any company that makes a pharmaceutical product, including research‑only items, to list every active, inactive, biological and synthetic component, submit the list to Oklahoma’s Board of Pharmacy, post it on a website and include it on product labeling. It also creates civil and criminal penalties for companies that fail to comply and gives consumers the right to sue. The measure is intended to increase transparency for patients and regulators.

AI-generated summary — may be incomplete or inaccurate. Verify against the official bill text.

Topics

Share